Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients

Affiliations

• ¹ Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France. estelle.balducci@aphp.fr.
• ² INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France. estelle.balducci@aphp.fr.
• ³ Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
• ⁴ INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France.
• ⁵ Laboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
• ⁶ Hematology Department, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
• ⁷ Department of Clinical Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
• ⁸ Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM U1163, Imagine Institute, Paris City University, Paris, France.
• ⁹ OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris City University, Paris, France.